|Market Cap (Intraday)||3.77B|
|2yr Forward PE||N/A|
CareDx, Inc. Stock, NASDAQ:CDNA
CareDx, Inc. operates as a transplant diagnostics company,which discovers, develops, and commercializes diagnostic solutions. Its product includes AlloMap, AlloSure, and Laboratory products. The company was founded on December 21, 1998 and is headquartered in Brisbane, CA.